Exporter

EN
FR
Azathioprine
Statut de médicament essentiel
Description générale

INN
Azathioprine
Codes ATC
L04AX01
Type de médicament
Chemical agent
Historique des statuts LME
Ajouté pour la première fois en 1979 (TRS 641) pour Failure or rejection of transplanted organs or tissues
Ajouté en 1997 (TRS 882) pour Psoriatic arthritis
Demande refusée en 2015 (TRS 994) pour Relapsing-remitting multiple sclerosis
Wikipédia
Azathioprine
DrugBank
Azathioprine
Recommandations
Section
Immunomodulators for non-malignant disease
  • Parenteral > General injections > IV: 100 mg in vial powder for injection (as sodium salt); 50 mg in vial powder for injection (as sodium salt)
  • Oral > Liquid: 10 mg per mL
  • Oral > Solid > tablet: 50 mg (scored); 25 mg
  • Oral > Solid: 50 mg
Indications
Failure or rejection of transplanted organs or tissues Relapsing-remitting multiple sclerosis
Section
Disease-modifying anti-rheumatic drugs (DMARDs)
  • Oral > Solid: 50 mg
Indications
Rheumatoid arthritis, serology unspecified Psoriatic arthritis